Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC16A2 |
| Upstream (Parents) |
|---|
| (<<) ABCA6 → SLC16A2 |
| (<<) C1R → SLC16A2 |
| Downstream (Children) |
|---|
| SLC16A2 → INS-IGF2///IGF2 (>>) |
| SLC16A2 → FXYD1 (>>) |
| SLC16A2 → RDX (>>) |
| SLC16A2 → PDE2A (>>) |
| SLC16A2 → XPO4 (>>) |
| SLC16A2 → NPY1R (>>) |
| SLC16A2 → SLC2A10 (>>) |
| SLC16A2 → PCDHB17 (>>) |
| SLC16A2 → LOC284440 (>>) |
| SLC16A2 → HMGN1 (>>) |
| SLC16A2 → PER3 (>>) |
